Completed PHASE4 INTERVENTIONAL 3-arm NCT01622972

Mode of Action of Moviprep

Mode of Action of Moviprep:Impact on Distribution of Intestinal Fluid and Colonic Microbiota

Sponsor: Norgine

Conditions Functional Constipation Irritable Bowel Syndrome Characterized by Constipation

Updated 5 times since 2017 Last updated: Apr 11, 2014 Started: Sep 30, 2011 Primary completion: Feb 28, 2014 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01622972, this PHASE4 trial focuses on Functional Constipation and Irritable Bowel Syndrome Characterized by Constipation and remains completed. Sponsored by Norgine, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Norgine
University of Nottingham

Data source: University of Nottingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nottingham, United Kingdom